Cardioprotection for 20 Years for Children With Cancer
A case is building for the routine use of dexrazoxane to protect the hearts of children with cancer being treated with doxorubicin.
United States Biosciences Covance Eric Chow Jonathan Friedberg Dexrazoxane Totect Baldrick Foundation
Source: medscape.com